M
MiNK Therapeutics, Inc. (INKT)
NCM – Real Time Price. Currency in USD
11.41
+0.46 (4.20%)
At close: May 12, 2026, 4:00 PM EDT
11.03
-0.38 (-3.33%)
After-hours: May 12, 2026, 6:49 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
11.41
+0.46 (4.20%)
At close: May 12, 2026, 4:00 PM EDT
11.03
-0.38 (-3.33%)
After-hours: May 12, 2026, 6:49 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $13.4M significantly exceed its total debt $5.2M, ensuring strong financial flexibility
Total current assets $13.8M exceed Total current liabilities $13.0M, highlighting excellent liquidity
Debt-to-equity ratio (-0.4) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$2.1M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.06 | 6.05 | 7.0 | |
| Quick ratio | 1.06 | 5.63 | 7.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 0.36 | 1.04 | 6.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 4.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -122K | -205K | -215K | -182K | -182K |
| Operating Income | -31M | -23M | -11M | -12M | -12M |
| Net Income | -28M | -22M | -11M | -12M | -12M |
| EBITDA | -31M | -23M | -10M | -12M | -12M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -10 | 1.0 |
| Next quarter | N/A | 17.92 | 5.0 |
| Current year | N/A | -11.43 | 1.0 |
| Next year | N/A | -5.67 | 1.0 |
| Weighted average score | 2.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 9.89 | 20 | -120.28 | 6.5 |
| Y/Y | 999 | -5.59 | 16.13 | -20.02 | 5.3 |
| 3y average | 999 | 18.64 | 25.08 | 31.6 | 9.8 |
| 5y average | 999 | -4.55 | 25.93 | -1.28 | 5.5 |
| Weighted average score | 6.8 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |